Patents by Inventor Richard J. Sciotti

Richard J. Sciotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxaborole analogs and uses thereof
    Patent number: 11691992
    Abstract: This application describes compounds, compositions, and methods which are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: July 4, 2023
    Assignees: Anacor Pharmaceuticals, Inc., The Government of the United States, as represented by the Secretary of the Army
    Inventors: Robert Toms Jacobs, Yang Liu, Richard J. Sciotti, Jason D. Speake, Gavin Alistair Whitlock, Paul Alan Glossop, Charles Eric Mowbray, Delphine Françoise Monique Launay, Stephen John Robinson
  • NOVEL OXABOROLE ANALOGS AND USES THEREOF
    Publication number: 20210253605
    Abstract: This application describes compounds, compositions, and methods which are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite.
    Type: Application
    Filed: February 11, 2021
    Publication date: August 19, 2021
    Inventors: Robert Toms Jacobs, Yang Liu, Richard J. Sciotti, Jason D. Speake, Gavin Alistair Whitlock, Paul Alan Glossop, Charles Eric Mowbray, Delphine Françoise Monique Launay, Stephen John Robinson
  • Oxaborole analogs and uses thereof
    Patent number: 10961261
    Abstract: This application describes compounds, compositions, and methods which are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite.
    Type: Grant
    Filed: March 1, 2018
    Date of Patent: March 30, 2021
    Assignees: Anacor Pharmaceuticals, Inc., The Government of the United States, as represented by the Secretaryof the Army
    Inventors: Robert Toms Jacobs, Yang Liu, Richard J. Sciotti, Jason D. Speake, Gavin Alistair Whitlock, Paul Alan Glossop, Charles Eric Mowbray, Delphine Françoise Monique Launay, Stephen John Robinson
  • NOVEL OXABOROLE ANALOGS AND USES THEREOF
    Publication number: 20200024289
    Abstract: This application describes compounds, compositions, and methods which are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite.
    Type: Application
    Filed: March 1, 2018
    Publication date: January 23, 2020
    Applicants: Anacor Pharmaceuticals, Inc., The Government of the United States, as represented by the Secretary of the Army, The Government of the United States, as represented by the Secretary of the Army
    Inventors: Robert Toms Jacobs, Yang Liu, Richard J. Sciotti, Jason D. Speake, Gavin Alistair Whitlock, Paul Alan Glossop, Charles Eric Mowbray, Delphine Françoise Monique Launay, Stephen John Robinson
  • Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
    Patent number: 9700562
    Abstract: Disclosed herein are triazine compounds and methods of making and using thereof to treat malaria, provide chemoprophylaxis, and/or treat or inhibit infection by one or more Plasmodium spp.
    Type: Grant
    Filed: April 5, 2016
    Date of Patent: July 11, 2017
    Assignee: The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
    Inventors: Richard J. Sciotti, Gregory A. Reichard, Kristina M. Pannone, Victor E. Zottig
  • Substituted triazines for malaria treatment and chemoprophylaxis
    Patent number: 9334246
    Abstract: Disclosed herein are triazine compounds and methods of making and using thereof to treat malaria, provide chemoprophylaxis, and/or treat or inhibit infection by one or more Plasmodium spp.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: May 10, 2016
    Assignee: The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
    Inventors: Richard J. Sciotti, Gregory A. Reichard, Kristina M. Pannone, Victor E. Zottig
  • Substituted Triazines for Malaria Treatment and Chemoprophylaxis
    Publication number: 20150210652
    Abstract: Disclosed herein are triazine compounds and methods of making and using thereof to treat malaria, provide chemoprophylaxis, and/or treat or inhibit infection by one or more Plasmodium spp.
    Type: Application
    Filed: March 13, 2014
    Publication date: July 30, 2015
    Inventors: Richard J. Sciotti, Gregory A. Reichard, Kristina M. Pannone, Victor E. Zottig
  • Oxazolidinone chemotherapeutic agents
    Publication number: 20020115669
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: August 29, 2001
    Publication date: August 22, 2002
    Inventors: Paul E. Wiedeman, Steven W. Djuric, Marina Pilushchev, Richard J. Sciotti, David J. Madar, Hana Kopecka
  • Oxazolidinone chemotherapeutic agents
    Patent number: 6410728
    Abstract: Compounds of the formula or therapeutically acceptable salts or prodrugs thereof, are useful for treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: June 25, 2002
    Assignee: Abbott Laboratories
    Inventors: Richard J. Sciotti, Stevan W. Djuric, Marina Pliushchev
  • OXAZOLIDINONE CHEMOTHERAPEUTIC AGENTS
    Publication number: 20020045625
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: June 19, 2001
    Publication date: April 18, 2002
    Inventors: Richard J. Sciotti, Stevan W. Djuric, Marina Pliushchev
  • AZOLE INHIBITORS OF CYTOKINE PRODUCTION
    Publication number: 20010044445
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: April 8, 1999
    Publication date: November 22, 2001
    Inventors: NWE Y. BAMAUNG, ANWER BASHA, STEVAN W. DJURIC, EARL J. GUBBINS, JAY R. LULY, NOAH P. TU, DAVID J. MADAR, USHA WARRIOR, PAUL E. WIEDEMAN, XUN ZHOU, RICHARD J. SCIOTTI, FRANK L. WAGENAAR
  • Oxazolidinone chemotherapeutic agents
    Patent number: 6277868
    Abstract: Compounds of formula (I) or therapeutically acceptable salts or prodrugs thereof, are useful for treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: August 21, 2001
    Assignee: Abbott Laboratories
    Inventors: Richard J. Sciotti, Stevan W. Djuric, Marina Pliushchev